In somatic cells, Holliday junctions can be formed between sister chromatids during the recombinational repair of DNA breaks or after replication fork demise. A variety of processes act upon Holliday junctions to remove them from DNA, in events that are critical for proper chromosome segregation. In human cells, the BLM protein, inactivated in individuals with Bloom's syndrome, acts in combination with topoisomerase IIIa, RMI1 and RMI2 (BTR complex) to promote the dissolution of double Holliday junctions 1, 2 . Cells defective for BLM exhibit elevated levels of sister chromatid exchanges (SCEs) and patients with Bloom's syndrome develop a broad spectrum of early-onset cancers caused by chromosome instability 3 . MUS81-EME1 (refs 4-7), SLX1-SLX4 13 ) also process Holliday junctions but, in contrast to the BTR complex, do so by endonucleolytic cleavage. Here we deplete these nucleases from Bloom's syndrome cells to analyse human cells compromised for the known Holliday junction dissolution/resolution pathways. We show that depletion of MUS81 and GEN1, or SLX4 and GEN1, from Bloom's syndrome cells results in severe chromosome abnormalities, such that sister chromatids remain interlinked in a side-by-side arrangement and the chromosomes are elongated and segmented. Our results indicate that normally replicating human cells require Holliday junction processing activities to prevent sister chromatid entanglements and thereby ensure accurate chromosome condensation. This phenotype was not apparent when both MUS81 and SLX4 were depleted from Bloom's syndrome cells, suggesting that GEN1 can compensate for their absence. Additionally, we show that depletion of MUS81 or SLX4 reduces the high frequency of SCEs in Bloom's syndrome cells, indicating that MUS81 and SLX4 promote SCE formation, in events that may ultimately drive the chromosome instabilities that underpin early-onset cancers associated with Bloom's syndrome.
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In somatic cells, Holliday junctions can be formed between sister chromatids during the recombinational repair of DNA breaks or after replication fork demise. A variety of processes act upon Holliday junctions to remove them from DNA, in events that are critical for proper chromosome segregation. In human cells, the BLM protein, inactivated in individuals with Bloom's syndrome, acts in combination with topoisomerase IIIa, RMI1 and RMI2 (BTR complex) to promote the dissolution of double Holliday junctions 1, 2 . Cells defective for BLM exhibit elevated levels of sister chromatid exchanges (SCEs) and patients with Bloom's syndrome develop a broad spectrum of early-onset cancers caused by chromosome instability 3 . MUS81-EME1 (refs 4-7), SLX1-SLX4 (refs [8] [9] [10] [11] and GEN1 (refs 12, 13) also process Holliday junctions but, in contrast to the BTR complex, do so by endonucleolytic cleavage. Here we deplete these nucleases from Bloom's syndrome cells to analyse human cells compromised for the known Holliday junction dissolution/resolution pathways. We show that depletion of MUS81 and GEN1, or SLX4 and GEN1, from Bloom's syndrome cells results in severe chromosome abnormalities, such that sister chromatids remain interlinked in a side-by-side arrangement and the chromosomes are elongated and segmented. Our results indicate that normally replicating human cells require Holliday junction processing activities to prevent sister chromatid entanglements and thereby ensure accurate chromosome condensation. This phenotype was not apparent when both MUS81 and SLX4 were depleted from Bloom's syndrome cells, suggesting that GEN1 can compensate for their absence. Additionally, we show that depletion of MUS81 or SLX4 reduces the high frequency of SCEs in Bloom's syndrome cells, indicating that MUS81 and SLX4 promote SCE formation, in events that may ultimately drive the chromosome instabilities that underpin early-onset cancers associated with Bloom's syndrome.
Our current understanding of the way in which Holliday junctions are processed in somatic cells suggests the three potential pathways illustrated in Supplementary Fig. 1 . These include the dissolution of double Holliday junctions by BLM-TOPIIIa-RMI1-RMI2 (BTR), which suppresses crossover formation between sister chromatids 1 , and the nucleolytic resolution of Holliday junctions by MUS81-EME1 (ref. 7) or GEN1 (ref. 12) that can lead to crossover or noncrossover products depending on the orientation of Holliday junction cleavage. Recently, it was shown that SLX4, a component of the SLX1-SLX4 nuclease complex that can also cleave Holliday junctions, associates with MUS81-EME1 and may provide a 'scaffold' function for several nuclease activities [8] [9] [10] [11] . The relative contribution of each Holliday junction processing pathway is currently unknown. However, given that intact Holliday junctions are a relatively poor substrate for MUS81-EME1 (refs 4, 5) , it is likely that the BTR complex provides the primary mechanism for the resolution of double Holliday junctions in human somatic cells at S phase. A further possibility is that resolution events mediated by MUS81-EME1, SLX1-SLX4 and/or GEN1 could substitute for the loss of BTR activity in Bloom's syndrome cells, either by cleaving the double Holliday junctions or other recombination intermediate structures (such as nicked Holliday junctions 14, 15 ), and thereby contribute to their viability.
Because nucleolytic cleavage mechanisms may be responsible for the elevated frequency of SCEs observed in Bloom's syndrome cells, we analysed SCE formation in metaphase spreads from the SV40-transformed Bloom's syndrome cell line GM08505 after short interfering RNA (siRNA)-mediated depletion of MUS81, SLX4 or GEN1. In all cases, efficient gene silencing was achieved, as measured by western blotting or quantitative reverse transcription PCR (RT-PCR) (Supplementary Fig. 2 ). Because depletion of SLX4 also decreases the levels of SLX1 (ref. 10) , as the stabilities of SLX1 and SLX4 are interdependent, the SLX4 depletion should be viewed as an SLX1-SLX4 depletion. Depletion of SLX4 does not affect the levels of MUS81 or EME1 (ref. 10) , or GEN1 (data not shown). We found that siRNA treatment against MUS81 or SLX4, but not GEN1, significantly reduced the frequency of SCEs (Fig. 1a, b) , as well as the formation of harlequin chromosomes (that is, chromosomes exhibiting more than five SCEs) ( Supplementary Fig. 3 ).
Although the SCE frequency in cells depleted for both MUS81 and GEN1 did not appear significantly different from MUS81-depleted cells, at least in metaphases that could be easily scored, many metaphase chromosomes looked abnormal after treatment with these siRNAs. Because these metaphases could not be scored for SCEs, it is possible that our scoring was biased towards those with only mild GEN1 and/or MUS81 depletion. We also observed decreased cell viability after dual siRNA treatment against GEN1 and MUS81, MUS81 and SLX4, or GEN1 and SLX4 (Fig. 1c) , indicating that loss of multiple Holliday junction processing pathways can lead to cell death even in the absence of exogenous DNA damage. Depletion of GEN1 with SLX4, or MUS81 with SLX4, had a greater impact upon cell viability than GEN1 and MUS81 siRNA treatment, suggesting that SLX4 might have a broader role than either of the other nucleases.
When the chromosome aberrations seen in the metaphase spreads prepared from GEN1-and MUS81-depleted cells were analysed, we observed a high percentage of cells in which the chromosomes were elongated and segmented (Fig. 2a , compare left and right panels with enlargements below). Indeed, most chromosomes exhibited a 'beadson-a-string' morphology. Similar results were obtained when the untransformed Bloom's syndrome fibroblast line GM01492 was treated with MUS81 and GEN1 siRNAs ( Fig. 2b and Supplementary  Fig. 4 ). Careful analysis of these spreads revealed the occasional appearance of single chromosomes that had an extreme defect in chromosome condensation (Fig. 2b, arrows) .
These observations, with measurements showing that the total number of chromosomes in these metaphases was comparable to control spreads (data not shown), indicated that the beads-on-a-string morphology might result from an aberrant chromosome condensation defect rather than break-induced chromosome rearrangements. To confirm this, we performed whole chromosome painting on chromosomes 4, 8 and X in GM01492 Bloom's syndrome cells after GEN1 and MUS81 siRNA targeting. We found that segmentation occurred within intact chromosomes and was not due to translocation events (Fig. 2c) . Indeed, although some chromosomal regions looked compact, others were more elongated and appeared as though held together by a thread of (nonstaining) DNA. Our interpretation of the extended and segmented chromosome structure is that regions showing normal condensation are linked to uncondensed regions of DNA. Generally, the uncondensed 
Bloom's-syndrome-derived cell line GM08505 
LETTER RESEARCH
regions were observed at equivalent positions on each of the two sister chromatids, which themselves remained tightly associated along their entire length. One possibility is that the loss of Holliday junction processing activity results, either directly or indirectly, in sister chromatid entanglements that prohibit normal chromosome condensation.
To quantify the observed segmentation phenotype, we counted chromosomes with more than three segments (S . 3) and scored metaphases with two or more segmented chromosomes as 'S . 3 positive' (Fig. 3a) . Using this scoring method, a baseline of 2% was observed with the control GM08505 Bloom's syndrome cells, whereas cells depleted for MUS81 or GEN1 contained 6% and 8% of S . 3 chromosomes, respectively (Fig. 3b) . In contrast, 56% of the Bloom's syndrome metaphases depleted for both GEN1 and MUS81 exhibited two or more S . 3 chromosomes (Fig. 3b, c) . Moreover, in 13% of these cells, the S . 3 phenotype was so severe that virtually all chromosomes in the spread were affected (Fig. 2a) . To enable the most simple quantification, these severely affected cells were designated '.9'. The abnormal phenotype was not influenced by the presence or absence of BrdU (an agent used in the earlier SCE analyses) (Supplementary Fig. 5 ). When the same scoring method was applied to the Bloom's syndrome cell line GM01492 after GEN1-and MUS81-depletion, we found that 46% of the cells (compared with 7% in control cells) showed an S . 3 phenotype, ruling out any cell-line-specific effects ( Supplementary Fig. 4) .
Importantly, the chromosome abnormalities observed in Bloom's syndrome cells depleted for both GEN1 and MUS81 were suppressed by exogenous expression of BLM protein, as shown by comparison of the BLM-defective cell line PSNG13 with its isogenic BLMcomplemented cell line PSNF5 after GEN1 and MUS81 siRNA treatment (Fig. 3d-f and Supplementary Fig. 6 ). We also failed to observe an increase in S . 3 chromosomes in the BLM-proficient cell line U2OS, despite a high depletion efficiency of GEN1 and MUS81 ( Supplementary Fig. 7 ). These results show that BLM is critical for the maintenance of genome stability, and that loss of Holliday junction processing activity caused by disruption of BLM, MUS81 and GEN1 leads to aberrant chromosome morphology.
In yeast, it has been shown that yen1 mus81 double mutants (Yen1 is the yeast orthologue of GEN1) are considerably more sensitive to DNA damage than the mus81 single mutant 16, 17 and that Mus81 and Yen1 can promote crossover formation during mitotic recombination 18 . These studies indicate that recombination intermediates normally resolved by Mus81 can also serve as substrates for Yen1. In mammalian cells, however, we currently have little information relating to the interplay between GEN1 and MUS81, or with SLX4 with which MUS81 interacts [8] [9] [10] [11] . Therefore, to gain our first insights into the genetic interactions between these proteins, we depleted combinations of either MUS81 1 SLX4, GEN1 1 SLX4 or, as before, GEN1 1 MUS81, and measured the extent of chromosome aberrations. We found that depletion of GEN1 and SLX4 in Bloom's syndrome cells resulted in an extremely severe phenotype, as measured by the formation of segmented chromosomes (Fig. 4) . The next most severe combination was caused by depletion of GEN1 and MUS81. In contrast, the chromosome abnormalities observed after siRNA treatment against both MUS81 and SLX4 were considerably less severe. These results favour the view that SLX4 plays a broad role, not only in a nuclease complex with SLX1, but also as a scaffold for the cooperative actions of other nucleases.
The severe phenotype observed after GEN1 and SLX4 depletion allowed us to perform two further experiments. First, time-course analyses revealed that S . 3 chromosomes were detectable 36 h after chromosomes is shown. c, As b but to illustrate phenotypic severity, the number of S . 3 chromosomes in each metaphase (n 5 50) was plotted in a scatter graph. Only metaphases with at least one S . 3 chromosome are shown, and those with more than nine segmented chromosomes were termed '.9'. d, Complementation of Bloom's syndrome cells with BLM restores chromosome stability. BLM-deficient PSNG13 and the BLM-complemented PNSF5 cell lines were treated with siRNA against GEN1 and MUS81, and analysed for abnormal metaphases using Giemsa staining. Scale bars, 10 mm. e, f, Metaphases (n 5 50) were analysed after control or GEN1 1 MUS81 siRNA treatment of PSNG13 and PSNF5 cells. Quantifications were performed as in Fig. 3b .
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siRNA treatment, and that the severity of the abnormal chromosome phenotype continued into the second mitotic division ( Supplementary  Fig. 8 ). After this point, high levels of cell inviability were observed (Fig. 1c) . Second, we found that the chromosome indentations were effectively free of SMC2 protein, confirming that the unusual phenotype was indeed due to a defect in proper chromosome condensation ( Supplementary Fig. 9 ).
These results begin to define the relative contributions of GEN1, MUS81 and SLX4 to Holliday junction processing in human mitotic cells already defective for BLM. Inactivation of MUS81, together with GEN1, effectively produces BLM-defective cells compromised for the known Holliday junction dissolution/resolution pathways. The resulting phenotype was the formation of highly segmented chromosomes with severe condensation defects. Similar results were observed by inactivation of GEN1 and SLX4, supporting the notion that SLX4 and MUS81 might work in the same pathway. Although this is the first time that such an aberrant chromosome morphology has been associated with defects in Holliday-junction processing, similar defects have been observed in human and mouse cells in response to ionizing radiation which causes a delay in DNA replication timing that, in turn, affects mitotic chromosome condensation 19 . Similarly, defects in DNA replication due to the mutation of key replication factors such as ORC2 also lead to segmented chromosome condensation morphology. Together, these studies indicate a potential link between DNA replication and the establishment of proper chromosome condensation, and it has been suggested that the timely completion of replication impacts upon the lateral condensation of a metaphase chromosome by helping to remove entanglements 20 . In our study, we suggest that sister chromatid entanglements, caused instead by defects in Holliday junction processing pathways, might lead to a related aberrant condensation phenotype. The beads-on-a-string chromosome morphology seen here, and the absence of significant break-induced chromosome translocations, indicates that the regions of under-condensed chromatin retain fine DNA threads that link the normally condensed regions.
Moreover, the tight side-by-side alignment of sister chromatids is suggestive of the persistence of unresolved bridges that accumulate after disruption of the three cellular Holliday junction processing pathways.
It has been shown that BLM protein localizes to ultrafine bridges at anaphase, and that these sites represent unresolved entanglements that occur at fragile sites after replication stress [21] [22] [23] . However, many ultrafine bridges derive from centromeric regions 21, 24 , whereas our work shows that the indentations corresponding to regions of undercondensed chromatin are distributed randomly along the length of each chromosome.
The aberrant chromosome morphology seen in the current experiments was suppressed by expression of the BLM protein, leading us to suggest that Holliday junction dissolution, a system that avoids SCEs, provides the primary mechanism for the processing of Holliday junctions in somatic cells. In the absence of this pathway, such as in cells derived from patients with Bloom's syndrome, elevated levels of SCEs are observed and we have shown that these can arise through the actions of MUS81 or SLX4. The precise role of SLX4 is currently unknown, as it may function either as a junction-specific nuclease with SLX1, or it may provide a scaffold for the cooperation of multiple nucleases within a multi-functional DNA processing complex. Loss of both BLM and MUS81 (or SLX4), however, did not result in a severe condensation phenotype, because mitotic cells possess a third pathway of Holliday junction resolution mediated by GEN1, for which we present the first functional evidence in vivo. It is likely that MUS81-EME1, SLX1-SLX4 and GEN1 can resolve Holliday junctions that persist in BLM-defective cells, although the bi-directional nature of their cleavage mechanism will, in contrast to the BTR complex, produce SCEs. We therefore suggest that the nucleolytic processing pathways provide additional mechanisms of resolution that can act upon intermediates that escape the attention of the BTR complex, thereby allowing chromosome segregation. Use of these alternatives may, however, come at a price because Bloom's syndrome cells exhibit genomic instability and patients suffer a broad spectrum of early-onset cancers. . Cells were transfected twice with siRNA within 24 h. For a single gene, 3 3 10 5 cells were transfected with 400-500 pmol of siRNA (Dharmacon) using 10 ml of Lipofectamine RNAiMAX (Invitrogen). For doublegene targeting, up to 800 pmol of siRNA was mixed and transfected with 20 ml Lipofectamine. Control non-targeting siRNAs were used at equivalent concentrations. The efficiency of each siRNA treatment was monitored by western blotting 60 h after the first, or 36 h after the second, transfection, or by quantitative RT-PCR 48 h after the first treatment. SCEs and metaphase chromosomes were monitored as described 28, 29 . The SCE technique relies upon the differential staining of the sister chromatids after replication in the presence of BrdU, followed by staining with Hoechst dye and Giemsa. Cell viability assays were performed 12 h after the second transfection with various siRNA combinations (MUS81 1 SLX4; GEN1 1 MUS81; GEN1 1 SLX4). The cells were then seeded in equal numbers (2,000 per well) in a 96-well plate (in triplicates), grown for a further 84 h and tested using the Cell-Titre Glo assay system (Promega). Chromosome painting was performed as described 30 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
